Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-5-17
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139042, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139043, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139044, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139045, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139046, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139047, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139048, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139049, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139050, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139051, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139052, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139053, http://linkedlifedata.com/resource/pubmed/xref/GENBANK/AF139054
pubmed:abstractText
The reverse transcriptase (RT) and protease genes from 12 human immunodeficiency virus type 2 (HIV-2)-infected individuals who had been exposed to antiretroviral drugs for longer than 6 months were examined for the presence of mutations which could be involved in drug resistance. Four individuals carried virus genotypes with amino acid substitutions potentially associated with resistance to nucleoside analogues: two at codon 70 (K-->R) and two at codon 184 (M-->V). Moreover, the latter two patients harbored a codon Q151M mutation which is associated to multidrug resistance in HIV-1, and one of these subjects carried some of the typically linked mutations at codons 65 and 69. With regard to the protease inhibitors, substitutions associated with resistance to protease inhibitors at codon 46 were observed in all individuals. Moreover, minor resistance mutations, as well as new ones of unknown meaning, were often seen in the protease gene. In conclusion, amino acid changes in the HIV-2 RT and protease genes which could be associated with drug resistance seem to occur at positions identical to those for HIV-1.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-10397528, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-1371274, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-1380789, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-1768377, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-1946342, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-2201691, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7509000, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7525966, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7527086, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7613867, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7685994, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7888232, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7933127, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-7984417, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-8171040, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9021180, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9171288, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9333041, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9450061, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9797203, http://linkedlifedata.com/resource/pubmed/commentcorrection/10747109-9875574
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1370-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10747109-Adolescent, pubmed-meshheading:10747109-Adult, pubmed-meshheading:10747109-Amino Acid Substitution, pubmed-meshheading:10747109-Anti-HIV Agents, pubmed-meshheading:10747109-Drug Resistance, Microbial, pubmed-meshheading:10747109-Female, pubmed-meshheading:10747109-HIV Infections, pubmed-meshheading:10747109-HIV Protease, pubmed-meshheading:10747109-HIV Reverse Transcriptase, pubmed-meshheading:10747109-HIV-2, pubmed-meshheading:10747109-Humans, pubmed-meshheading:10747109-Male, pubmed-meshheading:10747109-Middle Aged, pubmed-meshheading:10747109-Molecular Sequence Data, pubmed-meshheading:10747109-Mutation, pubmed-meshheading:10747109-RNA-Directed DNA Polymerase, pubmed-meshheading:10747109-Reverse Transcriptase Inhibitors, pubmed-meshheading:10747109-Sequence Analysis, DNA
pubmed:year
2000
pubmed:articleTitle
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.
pubmed:affiliation
Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't